Developing regional genetic counseling for southern Chinese with nonsyndromic hearing impairment: a unique mutational spectrum by Kaitian Chen et al.
Chen et al. Journal of Translational Medicine 2014, 12:64
http://www.translational-medicine.com/content/12/1/64RESEARCH Open AccessDeveloping regional genetic counseling for
southern Chinese with nonsyndromic hearing
impairment: a unique mutational spectrum
Kaitian Chen, Ling Zong, Min Liu, Xianren Wang, Wei Zhou, Yuan Zhan, Hui Cao, Chang Dong,
Haocheng Tang and Hongyan Jiang*Abstract
Background: Racial and regional factors are important for the clinical diagnosis of non-syndromic hearing
impairment. Comprehensive genetic analysis of deaf patients in different regions of China must be performed to
provide effective genetic counseling. To evaluate the mutational spectrum of south Chinese families, we performed
genetic analysis for non-syndromic hearing impairment in this population.
Methods: Complete clinical evaluations were performed on 701 unrelated patients with non-syndromic hearing
impairment from six provinces in south China. Each subject was screened for common mutations, including
SLC26A4 c.IVS7-2A > G, c.2168A > G; mitochondrial DNA m.1555A > G, m.1494C > T, m.7444G > A, m.7445A > G; GJB3
c.538C > T, c.547G > A; and WFS1 c.1901A > C, using pyrosequencing. GJB2 and SLC26A4 coding region mutation
detection were performed using Sanger sequencing.
Results: Genetic analysis revealed that among the etiology of non-syndromic hearing impairment, GJB2, SLC26A4,
and mitochondrial m.1555A > G mutations accounted for 18.0%, 13.1%, and 0.9%, respectively. Common mutations
included GJB2 c.235delC, c.109G > A, SLC26A4 c.IVS7-2A > G, c.1229 T > C, and mitochondrial m.1555A > G. The total
mutation rate was 45.1% in all patients examined in south China. Overall, the clear contribution of GJB2, SLC26A4,
and mitochondrial m.1555A > G to the etiology of the non-syndromic deafness population in south China was
32.0%.
Conclusions: Our study is the first genetic analysis of non-syndromic hearing impairment in south China, and
revealed that a clear genetic etiology accounted for 32.0% of non-syndromic hearing cases in patients from these
regions. The mutational spectrum of non-syndromic hearing impairment in the south Chinese population provides
useful and targeted information to aid in genetic counseling.
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Gene mutationBackground
Hereditary deafness is a genetically heterogeneous dis-
ease with an incidence rate of approximately 1/1000 [1].
Non-syndromic hearing impairment (NSHI) accounts
for 60-70% of inherited hearing impairments. Among
the plethora of deafness genes discovered in the past
decade, certain genes are more important than others* Correspondence: jhongy@mail.sysu.edu.cn
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SLC26A4, and the mitochondrial 12SrRNA gene have
been shown to have a high prevalence in NSHI [2-4].
China is a multiethnic, large country with a population
of at least 1.6 billion, which encompasses 9.6 million
square kilometers. Moreover, there are 27.80 million
Chinese people with hearing and speech disabilities; of
these, 20.04 million have a simple hearing disability [5].
Although a few genetic studies have been conducted on
Chinese patients with deafness [5-8], the large deafness
population and racial differences demand regional andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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inferred from other groups’ conclusions. For example, in
typical areas of China (Chifeng City in Inner Mongolia
and Nangtong City in JiangSu Province), GJB2 gene mu-
tations account for the etiology of approximately 18.31%
of patients with hearing loss, SLC26A4 mutations ac-
count for approximately 13.73%, and the mitochondrial
m.1555A > G mutation accounts for 1.76% [7]. However,
common molecular etiologies are rare in non-syndromic
Tibetan Chinese patients with hearing impairment [5].
No homozygous or compound heterozygous mutation of
the GJB2 or SLC26A4 gene was found, and the mi-
tochondrial m.1555A > G homogeneous mutation were
responsible for hearing loss in 1.75% of 114 Tibetan
patients.
Genetic counseling for deafness should fully take into
account the differences in regional backgrounds. There-
fore, the establishment of a specific mutational database
for different regional populations is indispensable. Al-
though there are northern [9], central region [7], Xinjiang
[10], Yunnan [11] and Tibet Chinese [5], the mutation
spectrum of NSHI in patients from south China has not
been examined (Figure 1). To extend the epidemiological
data on common gene mutations in the Chinese popu-
lation and to provide appropriate genetic testing and
counseling for patients with NSHI in south China, we
conducted a genetic analysis in this population.Figure 1 Geographical distribution of patients from six provinces (cirMethods
A total of 701 unrelated sporadic or familial cases of NSHI
were recruited from six provinces in south China, includ-
ing Guangdong, Guangxi, Hai’nan, Hu’nan, Fujian and
Jiangxi (Figure 1). Each patient underwent a complete
medical history and physical examination to exclude the
possibility of non-genetic causes or any syndromic find-
ings. An age-appropriate audiological examination was
performed, including pure-tone audiometry (PTA) and/or
auditory brainstem response (ABR), auditory steady state
response (ASSR), immittance testing, and distortion prod-
uct otoacoustic emissions (DPOAE). Temporal computed
tomography (CT) examination was conducted in 664 pa-
tients. Among these patients, 134 patients were diagnosed
as enlarged vestibular aqueduct (EVA) and 530 patients
had normal CT appearance. The rest 37 patients or their
guardians refused to receive temporal CT examination.
For control purposes, the study included 180 age-matched
individuals with normal hearing. The study was approved
by the institutional review board of the First Affiliated
Hospital, Sun Yat-sen University. Informed consent was
obtained from all patients or their guardians.
Blood samples were collected from the subjects, and
DNA isolation was performed using a standard chloro-
form extraction method. Targeted sequences were then
amplified by PCR. The coding exon (Exon 2) and flank-
ing intronic regions of GJB2 gene were PCR amplifiedcle in A) and an enlarged partial view (B).
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3′ and reverse primer 5′GGCCTACAGGGGTTTCAAAT
3′ [8]. Patients with monoallelic GJB2 coding region mu-
tations were additionally tested for GJB2 c.IVS1 + 1G >
A mutation or defects in GJB2 exon 1 and its basal pro-
moter [11,12].
Pyrosequencing was then utilized to detect SLC26A4 c.
IVS7-2A > G, c.2168A > G; mitochondrial m.1555A > G,
m.1494C >T, m.7444G >A, m.7445A >G; GJB3 c.538C >T,
c.547G >A, and WFS1 c.1901A > C in each subject. The
biotinylated PCR primers were designed according to the
Pyrosequencing Assay Design Software (Qiagen, Hilden,
Germany). Detailed procedures have been provided by the
manufacturer and previous study [13]. Briefly, bound bio-
tinylated single-stranded DNA was generated using PSQ
96 Sample Preparation Kit (Qiagen, Hilden, Germany).
After template preparation for pyrosequencing, an auto-
mated Pyrosequencing instrument, PSQ96 (Qiagen, Hilden,
Germany), was used to perform genotyping. The resulting
sequences were analyzed manually by visual inspection of
each pyrogram, automatically by the SNP evaluation soft-
ware (Qiagen, Hilden, Germany), or by both approaches.
Furthermore, 21 exons and flanking sequences from
the SLC26A4 gene were directly sequenced using an ABI
3730 Genetic Sequencer as previous study [14] of pa-
tients with EVA. Sequences were aligned and compared
with published sequences from the NCBI database
(GJB2: NG_008358.1; SLC26A4: NG_008489.1).
Results
Geographical and clinical characteristics of patients
We enrolled 701 unrelated patients (417 males and 284 fe-
males) diagnosed with NSHI from south China. TheTable 1 GJB2 mutation spectrum in patients with NSHI from s
Allele 1
Nucleotide AA change Nucleo
c.109G > A p.V37I c.109G
c.235delC Frameshift c.235d
c.235delC Frameshift c.109G
c.235delC Frameshift c.299-30
c.235delC Frameshift c.176-19
c.235delC Frameshift c.512ins
c.235delC Frameshift c.35d
c.235delC Frameshift c.257C
c.299-300delAT Frameshift c.299-30
c.512insAACG Frameshift c.257C
c.235delC Frameshift c.427C
c.235delC Frameshift c.605i
c.257C > G p.T86R c.176-19
c.109G > A p.V37I c.299-30geographical distribution covered six provinces (Figure 1).
Specifically, there were 238 cases from Guangdong, 92
cases from Jiangxi, 98 cases from Guangxi, 96 cases from
Fujian, 98 cases from Hainan, and 79 cases from Hu’nan.
The average patient age was 7.5 years (range: 11 months-
47 years), and 97.3% of the patients were Han Chinese.
Each individual demonstrated congenital hearing loss or
postlingual bilateral deafness that ranged from mild to
anacusis. The average onset age of patients with postlin-
gual NSHI was 8.71 ± 7.24 years. No goiter was discovered.Prevalent GJB2 mutations in patients with NSHI from
south China
GJB2 coding region sequencing identified ten known
pathogenic mutations (c.11G > A, c.35delG, c.109G > A,
c.176-191del16, c.235delC, c.257C > G, c.299-300delAT,
c.427C > T, c.512insAACG, and c.605ins46), two unclas-
sified variants (c.187G > T, c.368C > A), and five poly-
morphisms (c.79G > A, c.341A > G, c.186C > T, c.558G >
A and c.608 T > C). All GJB2 mutations identified in this
cohort were recessive. Dominant mutation was absent in
this cohort.
In total, 126 patients (18.0%, 126/701) carried a
homozygous or compound heterozygous GJB2 patho-
genic mutation (Table 1). The mutation c.235delC is
also the most prevalent among south Chinese; but
c.109G > A is most frequent in south Chinese than in
north Chinese. Another prevalent mutation, c.299-
300delAT [4,8] was less common, displaying a dis-
crepant genetic spectrum in south Chinese. As to allele
frequency, the c.235delC mutation was most commonly
observed (46.8%, 118/252), followed by the c.109G > Aouth China
Allele 2 No.
(Proportion)tide AA change
> A p.V37I 44(34.9%)
elC Frameshift 42(33.3%)
> A p.V37I 12(9.52%)
0delAT Frameshift 9(7.1%)
1del16 Frameshift 5(4.0%)
AACG Frameshift 4(3.17%)
elG Frameshift 1(0.8%)
> G p.T86R 1(0.8%)
0delAT Frameshift 1(0.8%)
> G p.T86R 2(1.6%)
> T p.R143W 1(0.8%)
ns46 Frameshift 1(0.8%)
1del16 Frameshift 2(1.6%)
0delAT Frameshift 1(0.8%)
Table 3 SLC26A4 mutation spectrum in patients with EVA
from south China
Allele 1 Allele 2 No.
Nucleotide AA change Nucleotide AA change
c.IVS7-2A > G Splice site c.IVS7-2A > G Splice site 29
c.IVS7-2A > G Splice site c.2086C > T p.Q696Stop 5
c.IVS7-2A > G Splice site c.2168A > G p.H723R 5
c.IVS7-2A > G Splice site c.1229C > T p.T410M 9
c.IVS7-2A > G Splice site c.2000 T > C p.F667S 1
c.IVS7-2A > G Splice site c.1691insA Frameshift 3
c.IVS7-2A > G Splice site c.1343C > T p.S448L 3
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12/252).
GJB2 mono-allelic mutations are shown in Table 2.
These patients with were additionally tested for GJB2 c.
IVS1 + 1G > A mutation or defects in GJB2 exon 1 and
its basal promoter, however, no pathogenic mutation
was identified. The proportion of c.109G > A heterozy-
gosity was 10.7% in patients with NSHI compared to ap-
proximately 6.1% in 180 normal control samples. GJB3
or GJB6 coding region mutations were further examined
in some of these patients and no pathogenic mutation
was detected [15].c.IVS7-2A > G Splice site c.754 T > C p.S252P 4
c.IVS7-2A > G Splice site c.1369A > T p.N457Y 1
c.IVS7-2A > G Splice site c.1079C > T p.A360V 4
c.IVS7-2A > G Splice site c.1540C > T p.Q514Stop 2
c.IVS7-2A > G Splice site c.1919G > A p.W641Stop 2
c.IVS7-2A > G Splice site c.IVS14-2A > G Splice site 1
c.IVS7-2A > G Splice site c.422 T > C p.F141S 1
c.IVS7-2A > G Splice site c.259G > T p.D87Y 1
c.754 T > C p.S252P c.754 T > C p.S252P 1
c.754 T > C p.S252P c.2168A > G p.H723R 1
c.754 T > C p.S252P c.1229C > T p.T410M 1
c.1229C > T p.T410M c.1229C > T p.T410M 1
c.1229C > T p.T410M c.1547insC Frameshift 3
c.1229C > T p.T410M c.259G > T p.D87Y 3
c.1229C > T p.T410M c.2086C > T p.Q696Stop 2
c.1229C > T p.T410M c.679G > C p.A227P 1
c.589G > A p.G197R c.1547insC Frameshift 1
c.2086C > T p.Q696Stop c.2086C > T p.Q696Stop 1
c.2168A > G p.H723R c.2168A > G p.H723R 3
c.2168A > G p.H723R c.1975G > C p.V659L 1
c.754 T > C p.S252P c.1975G > C p.V659L 1
c.1975G > C p.V659L c.2086C > T p.Q696Stop 1Hereditary heterogeneity of SLC26A4 mutations
correlated with EVA
We identified 80 patients from 134 patients with EVA car-
rying at least one SLC26A4 c.IVS7-2A >G or c.2168A >G
allele by pyrosequencing. In contrast, five c.IVS7-2A >G
and three c.2168A >G heterozygous alleles were detected
in 530 NSHI patients with normal temporal CT appear-
ance. Another 37 patients without temporal CT exa-
mination were negative for c.IVS7-2A >G or c.2168A >G
mutation. These results were confirmed by Sanger se-
quencing. SLC26A4 exons sequencing further confirmed
that 92 patients carried biallelic mutations and five pa-
tients exhibited mono-allelic mutations in the 134 patients
with EVA. SLC26A4 accounts for approximately 13.1%
(92/701) of the cases of NSHI in this population (Table 3),
secondary to the contribution of GJB2.
SLC26A4 exon sequencing confirmed four polymor-
phisms (c.IVS10 + 27C > A, c.IVS11 + 47 T > C, c.IVS19-
24 T > A, and c.IVS17-74G > A); 20 probable pathogenic
mutations, including 18 known mutations (c.259G > T,
c.413 T >A, c.589G > A, c.679G > C, c.754 T > C, c.IVS7-
2A >G, c.1079C > T, c.1229C > T, c.1343C > T, c.1540C >
T, c.1547insC, c.IVS14-2A >G, c.1691insA, c.1919G > A,
c.1975G >C, c.2000 T > C, c.2086C > T and c.2168A >G)
and two novel mutations (c.422 T > C, c.1369A > T). WeTable 2 Summary of GJB2 mono-allelic mutations in
patients with NSHI from south China
Nucleotide AA change Category No. (Proportion)
c.109G > A p.V37I Pathogenic 75(10.7%)
c.235delC Frameshift Pathogenic 5(0.71%)
c.512insAACG Frameshift Pathogenic 3(0.42%)
c.187G > T p.V63L Unclassified 2(0.29%)
c.186C > T p.N62N Polymorphism 1(0.14%)
c.558G > A p.T186T Polymorphism 2(0.29%)
c.11G > A p.G4D Pathogenic 2(0.29%)
c.368C > A p.T123N Unclassified 2(0.29%)
c.608 T > C p.I203T Polymorphism 6(0.85%)identified that the c.IVS7-2A >G mutation was most
prevalent (54.5%, 103/189), followed by c.1229C > T
(11.1%, 21/189, Table 3).
Low frequency of mitochondrial DNA 1555A > G mutation
Pyrosequencing identified an m.1555A > G mutation in
the mitochondrial DNA of six patients (Figure 2), and
four homoplasmy and two heteroplasmy mutations (the
mutational threshold was 92% and 96%, respectively). In
addition, a history of aminoglycoside exposure before
the onset of deafness was confirmed in these six cases.
Additional mutations, such as m.1494C > T, tRNAser(UCN)
m.7444G > A, and m.7445A >G, were absent. Therefore,
we failed to locate a common mitochondrial DNA muta-
tion in this cohort (0.9%, 6/701).
Figure 2 Pyrosequencing detection of mitochondrial DNA m.1555A > G homoplasmy (A), heteroplasmy (B), and wild-type (C).
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In total, 701 patients lacked GJB3 c.538C > T, c.547G >
A, and WFS1 c.1901A > C mutations, suggesting that
these variants are rare in south Chinese. Moreover, 200
individuals were further examined for GJB3 and GJB6
coding region mutations, including del(GJB6-D13S1830)
and del(GJB6-D13S1854) sequences; however, only two
subjects were heterozygous for c.250G > A or c.580G > A
mutations [15].
Genetic counseling for south Chinese patients with NSHI
The total carrier mutation rate constituted approxi-
mately 45.1% in our patient cohort, with a clear genetic
etiology in 32.0% of the patients with NSHI (Figure 3).
Discussion
Based on a relatively large cohort, the present study ana-
lyzed the mutational spectrum of NSHI in the popu-
lation of south China for the first time. It has been
established that the common deafness mutations for the
Chinese population are GJB2 c.235delC, c.299-300delAT,
c.176-191del16, c.35delG; GJB3 c.538C > T; SLC26A4 c.
IVS7-2A >G, c.2168A >G; and mitochondrial m.1555A >G
and m.1494C > T [8,10], whereas the major mutations
in the south Chinese population consist of GJB2
c.235delC, c.109G > A, c.299-300delAT, c.176-191del16;
SLC26A4 c.IVS7-2A > G and c.1229 T > C; and mito-
chondrial m.1555A >G. GJB2 exon sequencing is recom-
mended for each individual because it is simple, cheap
(25 RMB per sample), and can provide more information
(18%) than gene chips [10]. SLC26A4 exons sequencing is
suggested for patients with EVA. An extended and sys-
tematic study of the complete mitochondrial DNA se-
quence may provide significant further information for
assessment of patients with NSHI.
China consists of 56 ethnic countries that comprise a
population of over 1.6 billion. Given the heterogeneity ofFigure 3 The significance of genetic counseling services for NSHI in t
population of patients with NSHI could be diagnosed with hereditary deafn
the south China population of patients with NSHI.genetic deafness, ethnic and regional specific factors are
important. Although genetic analysis of patients from
the northern [9], central [7], Xinjiang [10], Yunnan [11],
and Tibet [5] areas of China have been reported, the
mutational spectrum of NSHI in south China - consist-
ing of the Guangdong province and the surrounding
areas - remained unclear. A genetic study of the south
China population may provide regional-specific muta-
tional information to improve the efficacy of clinical
genetic counseling. Therefore, the present results pro-
vide useful information for clinical application of mutant
gene detection in patients with deafness.
GJB2 gene mutations are diverse in different ethnic re-
gions (between 10–48.1%). The hereditary deafness web-
site (http://hereditaryhearingloss.org) lists at least 111
GJB2 mutations. The c.35delG mutation is most preva-
lent in Europe and the United States, compared with
c.235delC in East Asian populations and c.167delT in
Jewish populations [16]. We observed a GJB2 mutation
distribution of approximately 20% that was responsible
for NSHI in south China. The GJB2 mutation rate in
south China was identical to that of central and north-
ern China [4,6-11]. The c.109G > A mutation was very
common, although its pathogenicity remains controver-
sial. A study indicated that the c.109G > A mutation had
an allelic frequency of 6.7% (185/2744) in a Han patient
group (excluding all cases with two clearly pathogenic
mutations); this rate was significantly higher than the
control population (2.8%, 17/602; P =0.0003) [17]. These
results support the conclusion that GJB2 c.109G > A
should be reassigned to a pathogenic mutation. Our cell-
based in vitro functional assays study also indicated
that c.109G > A homozygote could impair connexin26
gap junctional coupling and should be assigned to patho-
genic mutation (unpublished data). In addition, there is a
lack of genetic information for the GJB2 mono-allelic mu-
tation, which makes genetic counseling for these patientshe south Chinese population. (A) In total, 32% of the south China
ess. (B) The carrying frequency of a common mutation was 45.1% in
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group is relatively high (6.1%) in our cohort. This may
partially be attributed to the small sample sizes and/or
selection bias; However, this frequency might reflect the
prevalence of c.109G > A in this cohort and c.109G > A
might be ascribed to founder effect in south Chinese.
Further population-based and functional studies are
recommended.
SLC26A4 mutations in Western countries and Asian
populations show regional and ethnic diversity in their
frequency and display mutational hot spots. For ex-
ample, SLC26A4 mutations account for approximately
4% of NSHI in the Caucasian population [18]. Evaluation
of previous Chinese domestic studies indicates that the
incidence of the SLC26A4 mutation may be between 12-
14% in patients with NSHI [19,20]. Our finding (13.1%)
is consistent with these results, illuminating the feasi-
bility of the SLC26A4 detection strategy inferred from
north China [7,9]. The c.IVS7-2A > G mutation is com-
mon in Eastern Asia. Several large cohort investigations
have reported a high prevalence of c.IVS7-2A > G in
the Chinese population (22.3-64.63%). In Koreans, the c.
IVS7-2A > G mutation accounts for 20% of mutant
SLC26A4 alleles and is the second most prevalent gen-
etic variant [21]. The c.IVS7-2A > G mutation has a low
incidence of approximately 3% in Japanese individuals
[22]. The distribution of mutant SLC26A4 alleles re-
vealed by our study suggests that mutation screening of
four exons (exons 19, 10, 17 and 15) following c.IVS7-
2A > G identification should be a priority for NSHI
genetic testing in patients with EVA. Besides, previous
studies [7,10,11,14,18] have revealed the close relationship
between SLC26A4 mutations and EVA. The absence of
SLC26A4 mutation in 37 patients without temporal CT in
our cohort could preliminarily exclude the possibility of
EVA in these patients.
Mitochondrial m.1555A > G mutation was detected at
a lower rate in southern China compared with previous
reports. The m.1555A > G mutation is observed in ap-
proximately 0.6-2.5% of Caucasian patients with NSHI
[23], but more frequently in the Asian population, in-
cluding China 2.9%, Japan 3% [24], and Indonesia 5.3%
[25]. The tRNAser(UCN) m.7445A > G and m.7444G > A
mitochondrial mutations may be involved in clinical
phenotype modifications. However, we failed to detect
tRNAser(UCN) m.7445A >G and m.7444G > A mutations;
therefore, they may be rare in the south China population.
Previous studies have found that digenic inheritance of
NSHI is caused by mutations in the GJB2 and GJB3 genes
[26]. However, we observed that both GJB3 and GJB6 ex-
hibited a low mutation rate [27,28]. In the present study,
701 cases lacked the c.538C > T or c.547G >A mutations
in GJB3. Additional screening of 200 subjects for muta-
tions in the GJB3 and GJB6 coding regions did not identifyany pathogenic mutations [15]. Meanwhile, lack of WFS1
c.1901A > C, a rare low-frequency mutation [29], excludes
the necessity of routine screening for this allele. Therefore,
our preliminary results indicate that the GJB3, GJB6,
and WFS1 c.1901A > C common gene mutations may be
minor in NSHI and are not recommended as alleles for
first-line screening.
Individualized genetic screening in south China may
improve the NSHI diagnostic efficiency and positivity
rate, to avoid unnecessary waste of economic and hu-
man resources. Therefore, larger epidemiological studies
of the genetic etiology of NSHI are recommended due
to the sample size limitations of the present study. New
genetic technology, such as targeted exon sequencing,
may shed further light on the genetic components of
NSHI in patients that lack common gene mutations.
Conclusions
We have conducted the first genetic analysis of NSHI in
south China, and revealed that a clear genetic etiology
accounted for 32.0% of cases. The NSHI mutational
spectrum of the south Chinese population provides use-
ful and important information for genetic counseling.
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